Bullous pemphigoid associated with dermatomyositis successfully controlled with minocycline [10]

Clinical and Experimental Dermatology

Volumn 28, Issue 5, 2003, Pages 563-564

  Tsukada, Y ^a   Kawase, Masaaki K ^a,c   Murashima, A ^a   Kitahora, T ^a   Hashimoto, T ^b   Komai, A ^b  

^a Department of Surgery and Clinical Research   (Japan)

^b KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHOTREXATE; MINOCYCLINE; PREDNISOLONE;

AGED; BLISTER; CASE REPORT; DERMATOMYOSITIS; DISEASE ASSOCIATION; ERYTHEMA; HUMAN; IMMUNOFLUORESCENCE; LABORATORY TEST; LETTER; MALE; PEMPHIGOID; PRIORITY JOURNAL; RASH; SKIN BIOPSY; SKIN EXAMINATION;

EID: 0042410952     PISSN: 03076938     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2230.2003.01355.x     Document Type: Letter

References (6)

1. Matsumura K, Amagai M, Nishikawa T et al. The majority of bullous pemphigoid and herpes gestationis serum samples react with the NCl6a domain of the 180-kDa bullous pemphigoid antigen. Arch Dermatol Res 1996; 188: 507-9.
2. Karelitz S, Welt SK. Dermatomyositis. Am J Dis Child 1932; 43: 1134-49.
3. Glover M, Leigh I. Dermatomyositis pemphigoides: a case with coexistent dermatomyositis and bullous pemphigoid. J Am Acad Dermatol 1992; 27: 849-52.
4. Iwai T, Muro Y, Ohashi M. Two cases of dermatomyositis with vesicular and bullous lesions (in Japanese). Hifubyo Rinsho (Tokyo) 1996; 18: 903-6.
5. Chan LS, Vanderlugt CJ, Hashimoto T et al. Epitope spreading: lessons from autoimmune skin diseases. J Invest Dermatol 1998; 110: 103-9.
6. Loo WJ, Kirtsching G, Wojnarowska F, Minocycline as a therapeutic option in bullous pemphigoid. Clin Exp Dermatol 2001; 26: 376-9.